###begin article-title 0
###xml 123 124 123 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn1">*</xref>
###xml 124 124 124 124 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn2"/>
Substrate Specificity of the Oxidoreductase ERp57 Is Determined Primarily by Its Interaction with Calnexin and Calreticulin*
###end article-title 0
###begin p 1
Both authors contributed equally to this work.
###end p 1
###begin p 2
###xml 185 214 185 214 <email xmlns:xlink="http://www.w3.org/1999/xlink">neil.bulleid@manchester.ac.uk</email>
 To whom correspondence should be addressed: The Michael Smith Bldg., Faculty of Life Sciences, University of Manchester, Oxford Road, Manchester M13 9PT. Fax: 44-161-275-5082; E-mail: neil.bulleid@manchester.ac.uk.
###end p 2
###begin p 3
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice
###end p 3
###begin p 4
 applies to Author Choice Articles
###end p 4
###begin p 5
The formation of disulfides within proteins entering the secretory pathway is catalyzed by the protein disulfide isomerase family of endoplasmic reticulum localized oxidoreductases. One such enzyme, ERp57, is thought to catalyze the isomerization of non-native disulfide bonds formed in glycoproteins with unstructured disulfide-rich domains. Here we investigated the mechanism underlying ERp57 specificity toward glycoprotein substrates and the interdependence of ERp57 and the calnexin cycle for their correct folding. Our results clearly show that ERp57 must be physically associated with the calnexin cycle to catalyze isomerization reactions with most of its substrates. In addition, some glycoproteins only require ERp57 for correct disulfide formation if they enter the calnexin cycle. Hence, the specificity of ER oxidoreductases is not only determined by the physical association of enzyme and substrate but also by accessory factors, such as calnexin and calreticulin in the case of ERp57. These conclusions suggest that the calnexin cycle has evolved with a specialized oxidoreductase to facilitate native disulfide formation in complex glycoproteins.
###end p 5
###begin p 6
###xml 42 56 42 56 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Wellcome Trust</grant-sponsor>
###xml 84 138 84 138 <grant-sponsor xmlns:xlink="http://www.w3.org/1999/xlink">Biotechnology and Biological Sciences Research Council</grant-sponsor>
###xml 300 313 300 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">advertisement</italic>
The work was supported by grants from the Wellcome Trust (Reference 074081) and the Biotechnology and Biological Sciences Research Council (Reference D00764). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
###end p 6
###begin p 7
###xml 0 15 0 15 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Author's Choice</italic>
Author's Choice-Final version full access.
###end p 7
###begin p 8
###xml 163 164 163 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fn" rid="fn4">3</xref>
###xml 452 453 452 453 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref1">1</xref>
###xml 620 621 620 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 756 764 756 764 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 824 831 824 831 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
The ability to form disulfide bonds within proteins entering the secretory pathway is essential for cell survival and occurs within the endoplasmic reticulum (ER).3 For proteins with few disulfides, the process can be catalyzed by oxidation of cysteine residues to form the correct, native disulfide; however, for proteins with several disulfides, an isomerization reaction is also required to correct non-native disulfides formed following oxidation (1). Both these reactions are catalyzed by a group of ER-resident proteins that belong to the protein disulfide isomerase (PDI) family, which comprises over 17 members (2). It is well established that PDI and several other family members are able to catalyze the formation and isomerization of disulfides in vitro, although the exact function of each of the family members in vivo is unknown. It is still an open question as to whether they all catalyze similar reactions and have distinct substrate specificities or whether they have distinct enzymatic functions related to the breaking and formation of disulfides.
###end p 8
###begin p 9
###xml 192 193 192 193 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref3">3</xref>
###xml 270 271 270 271 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 531 539 531 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 599 600 599 600 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref5">5</xref>
###xml 767 768 767 768 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 1281 1282 1281 1282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref7">7</xref>
###xml 1284 1285 1284 1285 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
###xml 1415 1416 1415 1416 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref9">9</xref>
###xml 1398 1413 <span type="species:ncbi:10633">simian virus 40</span>
For one member of the PDI family, the function and substrate specificity is a little clearer. ERp57 has been shown previously to interact specifically with glycoproteins during their folding (3). The enzyme is physically associated with either calnexin or calreticulin (4) and is therefore ideally placed to catalyze correct disulfide formation within proteins entering the calnexin/calreticulin cycle (referred to subsequently just as the calnexin cycle). In addition, the ability of ERp57 to catalyze the refolding of substrates in vitro is greatly enhanced if the substrate is bound to calnexin (5). Recently, substrates for the reduction or isomerization reaction catalyzed by ERp57 have been identified by trapping mixed disulfides between enzyme and substrate (6). Strikingly, there was an overrepresentation of substrate proteins with cysteine-rich domains containing little secondary structure, suggesting that the main function of ERp57 is in the isomerization of non-native disulfides. ERp57 has also been shown to function independently from the calnexin cycle. It is a component of the MHC class I loading complex where it forms a disulfide-linked complex with tapasin and is thought to either stabilize the complex or facilitate correct assembly of class I molecules (7, 8). Recently, ERp57 has been demonstrated to isomerize interchain disulfides in the major capsid protein, VP1, of simian virus 40 (9). The ability to dissociate VP1 pentamers by ERp57 does not require the substrate to interact with the calnexin cycle. Hence, it is still unclear how ERp57 recognizes its substrates, and in particular, whether this recognition is solely determined by an interaction with the calnexin cycle.
###end p 9
###begin p 10
###xml 212 214 212 214 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 329 331 329 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 1059 1060 1056 1057 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
The recognition of substrates by PDI is somewhat clearer in that one particular domain within the protein (the b' domain) has been shown to be primarily responsible for substrate recognition and peptide binding (10). The corresponding domain within ERp57 has been shown to be responsible for interaction with the calnexin cycle (11), suggesting that for ERp57, substrate recognition must occur outside this domain or is determined solely by substrate interaction with calnexin via its oligosaccharide side chain. Hence, the aim of our study was to evaluate the necessity of the calnexin cycle both for ERp57 to recognize its substrates and for correct folding of glycoproteins. ERp57 was found to be required for the efficient folding of one substrate, influenza virus hemagglutinin (HA), but only when it entered the calnexin cycle. HA did not require ERp57 to fold if it was blocked from entering the calnexin cycle. In contrast, beta1-integrin does not fold efficiently either if ERp57 was depleted or if ERp57 is blocked from entering the calnexin cycle (6). Although ERp57 may be dispensable for the folding of some glycoproteins, the interaction with calnexin commits them to an ERp57-dependent fate. We also found that the majority of ERp57 substrates need to enter the calnexin cycle to be acted upon by the enzyme, demonstrating that substrate specificity is primarily dependent upon substrate entry into the calnexin cycle.
###end p 10
###begin title 11
EXPERIMENTAL PROCEDURES
###end title 11
###begin p 12
###xml 0 25 0 25 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Antibodies and Cell Lines</italic>
###xml 223 225 220 222 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref12">12</xref>
###xml 572 575 569 572 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 26 31 <span type="species:ncbi:10090">Mouse</span>
###xml 155 161 <span type="species:ncbi:9986">rabbit</span>
###xml 228 234 <span type="species:ncbi:9986">Rabbit</span>
###xml 310 315 <span type="species:ncbi:10090">mouse</span>
###xml 374 379 <span type="species:ncbi:10090">mouse</span>
###xml 427 433 <span type="species:ncbi:9986">rabbit</span>
###xml 586 591 <span type="species:ncbi:10090">mouse</span>
Antibodies and Cell Lines-Mouse monoclonal antibody (8E3) to beta1-integrin was a gift from Martin Humphries (University of Manchester, Manchester, UK). A rabbit polyclonal antibody to calnexin was as described previously (12). Rabbit polyclonal anti-calreticulin was purchased from Stressgen (Ann Arbor, MI), mouse monoclonal anti-V5 antibody was from Invitrogen, PaSta.1 (mouse monoclonal to tapasin) and R.RING.4C (purified rabbit serum to TAP-1) were from Peter Cresswell (Yale University School of Medicine, New Haven, CT), and V5-agarose beads were from Sigma. ERp57-/- cells and mouse fibroblasts were a gift from Natalio Garbi and Gunter Hammerling, (German Cancer Research Center, Heidelberg, Germany).
###end p 12
###begin p 13
###xml 0 38 0 38 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Transcription and Translation in Vitro</italic>
###xml 402 404 402 404 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 582 583 575 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 585 587 578 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 589 591 582 584 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref15">15</xref>
###xml 765 766 758 759 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 949 950 932 933 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1083 1084 1060 1061 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 1310 1311 1278 1279 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 628 634 <span type="species:ncbi:9986">rabbit</span>
Transcription and Translation in Vitro-A cDNA clone encoding influenza virus HA strain A/Japan/305/57 (H2N2) was a gift from Mary-Jane Gething (University of Melbourne, Melbourne, Australia). A cDNA coding for tapasin was a gift from Peter Cresswell (Yale University School of Medicine). Transcription and translation in semipermeabilized (SP) cells were performed essentially as described previously (13). HA and tapasin cDNA were linearized with BamHI and transcribed using T7 polymerase. beta1-integrin, Ero1alpha, and HLA-B35 mRNA were prepared exactly as described previously (6, 14, 15). Transcripts were translated using rabbit reticulocyte lysate (Flexilysate, Promega) with SP cells added as required. Where appropriate, SP cells were preincubated with 1 mm castanospermine for 5 min or with gamma-interferon (200 units/ml) for 48 h. Initiation of protein synthesis was allowed to proceed for 5 min at 30 degreesC before inhibition with 1 mm ATCA (Sigma) followed by incubation at 30 degreesC to allow elongation and post-translational modification. At specified times, 25 mm NEM was added at 4 degreesC to prevent disulfide exchange. beta1-integrin translation products were immunoisolated prior to electrophoresis; otherwise, SP cells were isolated and resuspended in SDS-PAGE sample buffer (31.25 mm Tris-HCl, pH 6.8, 2% w/v SDS, 5% v/v glycerol, 0.01% w/v bromphenol blue).
###end p 13
###begin p 14
###xml 0 36 0 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Electrophoresis and Western Blotting</italic>
###xml 126 127 126 127 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 602 603 602 603 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 615 616 615 616 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 769 773 <span type="species:ncbi:9925">goat</span>
###xml 779 785 <span type="species:ncbi:9986">rabbit</span>
###xml 789 795 <span type="species:ncbi:9986">rabbit</span>
###xml 801 806 <span type="species:ncbi:10090">mouse</span>
###xml 837 848 <span type="species:ncbi:3704">horseradish</span>
Electrophoresis and Western Blotting-Samples for SDS-PAGE were resuspended in SDS-PAGE sample buffer, and dithiothreitol (50 mm) was added to reduce samples where indicated. All samples were boiled for 5 min before electrophoresis through 7.5% acrylamide gels, and proteins were transferred to nitrocellulose for Western blotting or fixed in 10% (v/v) acetic acid and 10% (v/v) methanol and then dried. Radiolabeled products were visualized by autoradiography using Kodak Biomax MR film (GRI, Essex, UK). For Western blotting, nitrocellulose was blocked with 3% milk in Tris/Tween-buffered saline (10 mm Tris, 150 mm NaCl, pH 7.5, 0.1% Tween 20). Primary antibody incubations were performed for 1 h at 22 degreesC with 3% milk, whereas secondary antibodies (polyclonal goat anti-rabbit or rabbit anti-mouse immunoglobulins conjugated to horseradish peroxidase (Dako, Ely, UK)) were diluted 1:2000 in Tris/Tween-buffered saline and again incubated at 22 degreesC for 1 h. Products were visualized using enhanced chemiluminescent substrate (Perbio, Northumberland, UK) and Fuji Super RX film (Fujifilm UK, Bedford, UK).
###end p 14
###begin p 15
###xml 0 41 0 41 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Creation of ERp57 R282A Stable Cell Lines</italic>
###xml 42 47 <span type="species:ncbi:9606">Human</span>
###xml 221 226 <span type="species:ncbi:9606">human</span>
Creation of ERp57 R282A Stable Cell Lines-Human ERp57 was mutated to change arginine 282 to alanine (primer sequences available on request). Plasmids were linearized with SspI before transfecting into subconfluent HT1080 human fibroblasts with FuGENE 8 (Roche Applied Science) according to the manufacturer's instructions. Stable cell lines were selected with G418 (Sigma) for 14 days before colonies were isolated and screened for expression of ERp57-V5.
###end p 15
###begin p 16
###xml 0 13 0 13 <italic xmlns:xlink="http://www.w3.org/1999/xlink">AMS Treatment</italic>
###xml 74 77 74 77 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 97 98 97 98 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 136 137 136 137 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 309 310 309 310 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 378 379 378 379 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 473 474 473 474 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 582 583 576 577 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
AMS Treatment-HA mRNA was translated in the presence of wild-type or ERp57-/- SP cells. ATCA (1 mm) was added after 5 min, and NEM (25 mm) was added after 30 min. Cells were pelleted, lysed cellular debris was removed, and cleared lysates were boiled with 1% SDS for 3 min. Tris[2-carboxyethyl]phosphine (10 mm) was added and incubated at room temp for 5 min, and then AMS (30 mm) was added for 1 h at room temperature. For reduced control, dithiothreitol was added to 20 mm for 3 min at 30 degreesC prior to NEM addition. For oxidized control, dipyridyl disulphide was added to 1 mm for the same period.
###end p 16
###begin p 17
###xml 0 17 0 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">BMH Cross-linking</italic>
###xml 83 84 83 84 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 167 168 161 162 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
BMH Cross-linking-HT1080 cells in adherent culture were treated for 10 min with 1 mm BMH (Pierce) at 4 degreesC, and cross-linking was quenched by the addition of 10 mm dithiothreitol. Cells were subsequently lysed, and V5-tagged ERp57 was immunoisolated prior to SDS-PAGE and Western blotting.
###end p 17
###begin p 18
###xml 0 35 0 35 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Two-dimensional Gel Electrophoresis</italic>
###xml 167 168 167 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
Two-dimensional Gel Electrophoresis-Non-reducing/reducing two-dimensional electrophoresis and substrate identification were performed exactly as described previously (6).
###end p 18
###begin title 19
RESULTS AND DISCUSSION
###end title 19
###begin p 20
###xml 0 66 0 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Disulfide Bond Formation in Substrates Entering the Calnexin Cycle</italic>
###xml 182 184 182 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 395 396 392 393 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 398 400 395 397 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
###xml 328 348 <span type="species:ncbi:11033">Semliki forest virus</span>
Disulfide Bond Formation in Substrates Entering the Calnexin Cycle-The requirement for ERp57 to facilitate efficient disulfide formation varies depending upon the substrate protein (16). For some proteins like HA and beta1-integrin, there is a clear defect of folding in an ERp57 knockout cell line; however, for others such as Semliki forest virus E1 and p62 proteins, there is no such defect (6, 16). Such a deficiency in the folding of HA in the absence of ERp57 could be due to ERp57 being the only oxidoreductase that can catalyze correct disulfide formation in HA, or it could be a consequence of HA entering the calnexin cycle, thereby preventing access by other PDI family members.
###end p 20
###begin p 21
###xml 77 85 77 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 271 273 271 273 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 472 474 472 474 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref17">17</xref>
###xml 618 620 618 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref18">18</xref>
###xml 841 842 841 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 835 842 835 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 844 850 844 850 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 6</italic>
###xml 930 935 930 935 <italic xmlns:xlink="http://www.w3.org/1999/xlink">upper</italic>
###xml 957 962 957 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lower</italic>
###xml 968 970 968 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 1092 1094 1092 1094 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref13">13</xref>
###xml 1184 1185 1184 1185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 1178 1185 1178 1185 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>A</italic></xref>
###xml 1187 1193 1187 1193 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 5</italic>
###xml 1836 1838 1836 1838 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref19">19</xref>
To address this question, we followed disulfide formation of HA in a SP cell in vitro translation system. In such a system, SP cells prepared from cells grown in culture are added to a reticulocyte lysate in the presence of an RNA transcript and radiolabeled amino acid (13). The reticulocyte lysate does not contain added reducing agent; therefore, disulfide bond formation can occur co- and post-translationally within proteins translocated into the ER of the SP cells (17). The electrophoretic mobility of the reduced, native, and disulfide-bonded intermediates of HA have been characterized extensively elsewhere (18), allowing us to follow folding by assessing the mobility of translation products on non-reducing gels. When the mobility of translation products was analyzed following reduction, two distinct bands were observed (Fig. 1A, lane 6). We have previously demonstrated that these bands correspond to glycosylated (upper) and unglycosylated (lower) HA (13). The unglycosylated material is not translocated as we have shown previously that it can be digested with proteinase K (13). When the same translation products were separated under non-reducing conditions (Fig. 1A, lane 5), the glycosylated HA migrated as a distinct band migrating faster through the gel, demonstrating that disulfide bonds had formed. The unglycosylated protein also migrated faster through the gel but appeared as a smear, indicating that a heterogeneous population of disulfide-bonded species had formed. Hence, in our SP cell system, HA was translated and translocated, and the glycosylated protein was folded into a form with a mobility corresponding to that of the fully oxidized, correctly folded protein. The unglycosylated material formed disulfide bonds, but these were heterogeneous in nature, indicating that, as described previously (19), in the absence of glycosylation, HA does not fold correctly.
###end p 21
###begin p 22
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 1.</label>
###xml 9 102 9 102 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Requirement for ERp57 in HA maturation is dependent upon interaction with the calnexin cycle.</bold>
###xml 102 103 102 103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 105 106 105 106 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 108 109 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 115 116 115 116 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 188 190 188 190 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 200 203 200 203 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 214 216 214 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KO</italic>
###xml 237 238 237 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 243 244 243 244 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 300 303 300 303 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CST</italic>
###xml 306 307 306 307 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 312 313 312 313 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 552 553 552 553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 555 561 555 561 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 6</italic>
###xml 564 567 564 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITs</italic>
###xml 614 615 614 615 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 634 640 634 640 <italic xmlns:xlink="http://www.w3.org/1999/xlink">unglyc</italic>
###xml 666 667 666 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 705 706 705 706 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 732 733 732 733 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 735 736 735 736 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 738 739 738 739 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 745 746 745 746 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 748 754 748 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 849 854 849 854 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Co-IP</italic>
###xml 899 902 899 902 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cnx</italic>
###xml 914 917 914 917 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crt</italic>
###xml 933 934 933 934 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 9 1181 9 1181 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="23"><bold>Requirement for ERp57 in HA maturation is dependent upon interaction with the calnexin cycle.</bold><italic>A</italic>, <italic>B</italic>, <italic>D</italic>, and <italic>E</italic>, translation was performed in the presence of SP cells from wild-type (<italic>WT</italic>) or ERp57<sup>-/-</sup> knockout (<italic>KO</italic>) mouse fibroblasts (<italic>A</italic> and <italic>B</italic>) and the same cells preincubated with castanospermine (<italic>CST</italic>) (<italic>D</italic> and <italic>E</italic>). Translation initiation was blocked with ATCA after 5 min, and then NEM was added and cells were harvested at the indicated times before non-reducing SDS-PAGE. All samples were run under non-reducing conditions apart from the gel inset (<italic>A</italic>, <italic>lane 6</italic>). <italic>ITs</italic>, intermediates in native disulfide formation; <italic>R</italic>, reduced protein; <italic>unglyc</italic>, unglycosylated protein; <italic>N</italic>, correctly disulfide-bonded protein. <italic>C</italic>, HA was translated as in <italic>A</italic>, <italic>B</italic>, <italic>D</italic>, and <italic>E</italic>, <italic>lane 4</italic>. Cells were harvested and lysed, and endogenous calnexin was immunoisolated. Co-precipitated (<italic>Co-IP</italic>) HA was analyzed under reducing conditions. <italic>Cnx</italic>, calnexin; <italic>Crt</italic>, calreticulin. <italic>F</italic>, for each time point in each folding time course, the total amount of glycosylated HA was calculated by densitometry. The fully folded material is given as a percentage of the total. Each time point is an average from three separate time courses.</p>
###xml 9 1181 9 1181 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="23"><bold>Requirement for ERp57 in HA maturation is dependent upon interaction with the calnexin cycle.</bold><italic>A</italic>, <italic>B</italic>, <italic>D</italic>, and <italic>E</italic>, translation was performed in the presence of SP cells from wild-type (<italic>WT</italic>) or ERp57<sup>-/-</sup> knockout (<italic>KO</italic>) mouse fibroblasts (<italic>A</italic> and <italic>B</italic>) and the same cells preincubated with castanospermine (<italic>CST</italic>) (<italic>D</italic> and <italic>E</italic>). Translation initiation was blocked with ATCA after 5 min, and then NEM was added and cells were harvested at the indicated times before non-reducing SDS-PAGE. All samples were run under non-reducing conditions apart from the gel inset (<italic>A</italic>, <italic>lane 6</italic>). <italic>ITs</italic>, intermediates in native disulfide formation; <italic>R</italic>, reduced protein; <italic>unglyc</italic>, unglycosylated protein; <italic>N</italic>, correctly disulfide-bonded protein. <italic>C</italic>, HA was translated as in <italic>A</italic>, <italic>B</italic>, <italic>D</italic>, and <italic>E</italic>, <italic>lane 4</italic>. Cells were harvested and lysed, and endogenous calnexin was immunoisolated. Co-precipitated (<italic>Co-IP</italic>) HA was analyzed under reducing conditions. <italic>Cnx</italic>, calnexin; <italic>Crt</italic>, calreticulin. <italic>F</italic>, for each time point in each folding time course, the total amount of glycosylated HA was calculated by densitometry. The fully folded material is given as a percentage of the total. Each time point is an average from three separate time courses.</p></caption>
###xml 1181 1181 1181 1181 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0090965720001"/>
###xml 0 1181 0 1181 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig1"><label>FIGURE 1.</label><caption><p textid="23"><bold>Requirement for ERp57 in HA maturation is dependent upon interaction with the calnexin cycle.</bold><italic>A</italic>, <italic>B</italic>, <italic>D</italic>, and <italic>E</italic>, translation was performed in the presence of SP cells from wild-type (<italic>WT</italic>) or ERp57<sup>-/-</sup> knockout (<italic>KO</italic>) mouse fibroblasts (<italic>A</italic> and <italic>B</italic>) and the same cells preincubated with castanospermine (<italic>CST</italic>) (<italic>D</italic> and <italic>E</italic>). Translation initiation was blocked with ATCA after 5 min, and then NEM was added and cells were harvested at the indicated times before non-reducing SDS-PAGE. All samples were run under non-reducing conditions apart from the gel inset (<italic>A</italic>, <italic>lane 6</italic>). <italic>ITs</italic>, intermediates in native disulfide formation; <italic>R</italic>, reduced protein; <italic>unglyc</italic>, unglycosylated protein; <italic>N</italic>, correctly disulfide-bonded protein. <italic>C</italic>, HA was translated as in <italic>A</italic>, <italic>B</italic>, <italic>D</italic>, and <italic>E</italic>, <italic>lane 4</italic>. Cells were harvested and lysed, and endogenous calnexin was immunoisolated. Co-precipitated (<italic>Co-IP</italic>) HA was analyzed under reducing conditions. <italic>Cnx</italic>, calnexin; <italic>Crt</italic>, calreticulin. <italic>F</italic>, for each time point in each folding time course, the total amount of glycosylated HA was calculated by densitometry. The fully folded material is given as a percentage of the total. Each time point is an average from three separate time courses.</p></caption><graphic xlink:href="zbc0090965720001"/></fig>
###xml 218 223 <span type="species:ncbi:10090">mouse</span>
FIGURE 1.Requirement for ERp57 in HA maturation is dependent upon interaction with the calnexin cycle.A, B, D, and E, translation was performed in the presence of SP cells from wild-type (WT) or ERp57-/- knockout (KO) mouse fibroblasts (A and B) and the same cells preincubated with castanospermine (CST) (D and E). Translation initiation was blocked with ATCA after 5 min, and then NEM was added and cells were harvested at the indicated times before non-reducing SDS-PAGE. All samples were run under non-reducing conditions apart from the gel inset (A, lane 6). ITs, intermediates in native disulfide formation; R, reduced protein; unglyc, unglycosylated protein; N, correctly disulfide-bonded protein. C, HA was translated as in A, B, D, and E, lane 4. Cells were harvested and lysed, and endogenous calnexin was immunoisolated. Co-precipitated (Co-IP) HA was analyzed under reducing conditions. Cnx, calnexin; Crt, calreticulin. F, for each time point in each folding time course, the total amount of glycosylated HA was calculated by densitometry. The fully folded material is given as a percentage of the total. Each time point is an average from three separate time courses.
###end p 22
###begin p 23
###xml 0 93 0 93 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Requirement for ERp57 in HA maturation is dependent upon interaction with the calnexin cycle.</bold>
###xml 93 94 93 94 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 96 97 96 97 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 99 100 99 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 106 107 106 107 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 179 181 179 181 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 191 194 191 194 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 205 207 205 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KO</italic>
###xml 228 229 228 229 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 234 235 234 235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 291 294 291 294 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CST</italic>
###xml 297 298 297 298 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 303 304 303 304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 543 544 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 546 552 546 552 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 6</italic>
###xml 555 558 555 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ITs</italic>
###xml 605 606 605 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 625 631 625 631 <italic xmlns:xlink="http://www.w3.org/1999/xlink">unglyc</italic>
###xml 657 658 657 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
###xml 696 697 696 697 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 723 724 723 724 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 726 727 726 727 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 729 730 729 730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 736 737 736 737 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 739 745 739 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 840 845 840 845 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Co-IP</italic>
###xml 890 893 890 893 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cnx</italic>
###xml 905 908 905 908 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crt</italic>
###xml 924 925 924 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 209 214 <span type="species:ncbi:10090">mouse</span>
Requirement for ERp57 in HA maturation is dependent upon interaction with the calnexin cycle.A, B, D, and E, translation was performed in the presence of SP cells from wild-type (WT) or ERp57-/- knockout (KO) mouse fibroblasts (A and B) and the same cells preincubated with castanospermine (CST) (D and E). Translation initiation was blocked with ATCA after 5 min, and then NEM was added and cells were harvested at the indicated times before non-reducing SDS-PAGE. All samples were run under non-reducing conditions apart from the gel inset (A, lane 6). ITs, intermediates in native disulfide formation; R, reduced protein; unglyc, unglycosylated protein; N, correctly disulfide-bonded protein. C, HA was translated as in A, B, D, and E, lane 4. Cells were harvested and lysed, and endogenous calnexin was immunoisolated. Co-precipitated (Co-IP) HA was analyzed under reducing conditions. Cnx, calnexin; Crt, calreticulin. F, for each time point in each folding time course, the total amount of glycosylated HA was calculated by densitometry. The fully folded material is given as a percentage of the total. Each time point is an average from three separate time courses.
###end p 23
###begin p 24
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 2.</label>
###xml 9 77 9 77 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ERp57 is not required for full oxidation of glycosylated substrates.</bold>
###xml 131 133 131 133 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 136 143 136 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 145 146 145 146 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 148 149 148 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 151 152 151 152 <italic xmlns:xlink="http://www.w3.org/1999/xlink">7</italic>
###xml 158 159 158 159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">8</italic>
###xml 169 172 169 172 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 183 185 183 185 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KO</italic>
###xml 188 195 188 195 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 197 198 197 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 204 205 204 205 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 379 381 379 381 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR</italic>
###xml 384 391 384 391 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 396 397 396 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 424 425 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 428 437 428 437 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3&#8211;8</italic>
###xml 560 567 560 567 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 5</italic>
###xml 572 573 572 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 741 744 741 744 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DTT</italic>
###xml 748 754 748 754 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 7</italic>
###xml 796 799 796 799 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DPS</italic>
###xml 803 809 803 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 8</italic>
###xml 9 833 9 833 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="25"><bold>ERp57 is not required for full oxidation of glycosylated substrates.</bold> HA mRNA was translated in the presence of wild-type (<italic>WT</italic>) (<italic>lanes 1</italic>, <italic>3</italic>, <italic>5</italic>, <italic>7</italic>, and <italic>8</italic>) or ERp57<sup>-/-</sup> knockout (<italic>KO</italic>) (<italic>lanes 2</italic>, <italic>4</italic>, and <italic>6</italic>) SP cells. ATCA was added after 5 min, and free thiols were alkylated with NEM after 30 min. Cells were harvested, and translated products were analyzed under non-reducing (<italic>NR</italic>) (<italic>lanes 1</italic> and <italic>2</italic>) and reducing conditions (<italic>R</italic>) (<italic>lanes 3&#8211;8</italic>). In addition, samples of each were treated with Tris[2-carboxyethyl]phosphine and AMS to modify disulfide linked thiols (<italic>lanes 5</italic> and <italic>6</italic>). As controls for AMS modification, the process was repeated with each protein translated with wild-type SP cells and cysteine residues fully reduced (dithiothreitol (<italic>DTT</italic>)) (<italic>lane 7</italic>) or fully oxidized (dipyridyl disulfide (<italic>DPS</italic>)) (<italic>lane 8</italic>) prior to NEM addition.</p>
###xml 9 833 9 833 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="25"><bold>ERp57 is not required for full oxidation of glycosylated substrates.</bold> HA mRNA was translated in the presence of wild-type (<italic>WT</italic>) (<italic>lanes 1</italic>, <italic>3</italic>, <italic>5</italic>, <italic>7</italic>, and <italic>8</italic>) or ERp57<sup>-/-</sup> knockout (<italic>KO</italic>) (<italic>lanes 2</italic>, <italic>4</italic>, and <italic>6</italic>) SP cells. ATCA was added after 5 min, and free thiols were alkylated with NEM after 30 min. Cells were harvested, and translated products were analyzed under non-reducing (<italic>NR</italic>) (<italic>lanes 1</italic> and <italic>2</italic>) and reducing conditions (<italic>R</italic>) (<italic>lanes 3&#8211;8</italic>). In addition, samples of each were treated with Tris[2-carboxyethyl]phosphine and AMS to modify disulfide linked thiols (<italic>lanes 5</italic> and <italic>6</italic>). As controls for AMS modification, the process was repeated with each protein translated with wild-type SP cells and cysteine residues fully reduced (dithiothreitol (<italic>DTT</italic>)) (<italic>lane 7</italic>) or fully oxidized (dipyridyl disulfide (<italic>DPS</italic>)) (<italic>lane 8</italic>) prior to NEM addition.</p></caption>
###xml 833 833 833 833 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0090965720002"/>
###xml 0 833 0 833 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig2"><label>FIGURE 2.</label><caption><p textid="25"><bold>ERp57 is not required for full oxidation of glycosylated substrates.</bold> HA mRNA was translated in the presence of wild-type (<italic>WT</italic>) (<italic>lanes 1</italic>, <italic>3</italic>, <italic>5</italic>, <italic>7</italic>, and <italic>8</italic>) or ERp57<sup>-/-</sup> knockout (<italic>KO</italic>) (<italic>lanes 2</italic>, <italic>4</italic>, and <italic>6</italic>) SP cells. ATCA was added after 5 min, and free thiols were alkylated with NEM after 30 min. Cells were harvested, and translated products were analyzed under non-reducing (<italic>NR</italic>) (<italic>lanes 1</italic> and <italic>2</italic>) and reducing conditions (<italic>R</italic>) (<italic>lanes 3&#8211;8</italic>). In addition, samples of each were treated with Tris[2-carboxyethyl]phosphine and AMS to modify disulfide linked thiols (<italic>lanes 5</italic> and <italic>6</italic>). As controls for AMS modification, the process was repeated with each protein translated with wild-type SP cells and cysteine residues fully reduced (dithiothreitol (<italic>DTT</italic>)) (<italic>lane 7</italic>) or fully oxidized (dipyridyl disulfide (<italic>DPS</italic>)) (<italic>lane 8</italic>) prior to NEM addition.</p></caption><graphic xlink:href="zbc0090965720002"/></fig>
FIGURE 2.ERp57 is not required for full oxidation of glycosylated substrates. HA mRNA was translated in the presence of wild-type (WT) (lanes 1, 3, 5, 7, and 8) or ERp57-/- knockout (KO) (lanes 2, 4, and 6) SP cells. ATCA was added after 5 min, and free thiols were alkylated with NEM after 30 min. Cells were harvested, and translated products were analyzed under non-reducing (NR) (lanes 1 and 2) and reducing conditions (R) (lanes 3-8). In addition, samples of each were treated with Tris[2-carboxyethyl]phosphine and AMS to modify disulfide linked thiols (lanes 5 and 6). As controls for AMS modification, the process was repeated with each protein translated with wild-type SP cells and cysteine residues fully reduced (dithiothreitol (DTT)) (lane 7) or fully oxidized (dipyridyl disulfide (DPS)) (lane 8) prior to NEM addition.
###end p 24
###begin p 25
###xml 0 68 0 68 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ERp57 is not required for full oxidation of glycosylated substrates.</bold>
###xml 122 124 122 124 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 127 134 127 134 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 136 137 136 137 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 139 140 139 140 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 142 143 142 143 <italic xmlns:xlink="http://www.w3.org/1999/xlink">7</italic>
###xml 149 150 149 150 <italic xmlns:xlink="http://www.w3.org/1999/xlink">8</italic>
###xml 160 163 160 163 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 174 176 174 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">KO</italic>
###xml 179 186 179 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 188 189 188 189 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 195 196 195 196 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 370 372 370 372 <italic xmlns:xlink="http://www.w3.org/1999/xlink">NR</italic>
###xml 375 382 375 382 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 387 388 387 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 415 416 415 416 <italic xmlns:xlink="http://www.w3.org/1999/xlink">R</italic>
###xml 419 428 419 428 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3&#8211;8</italic>
###xml 551 558 551 558 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 5</italic>
###xml 563 564 563 564 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 732 735 732 735 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DTT</italic>
###xml 739 745 739 745 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 7</italic>
###xml 787 790 787 790 <italic xmlns:xlink="http://www.w3.org/1999/xlink">DPS</italic>
###xml 794 800 794 800 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 8</italic>
ERp57 is not required for full oxidation of glycosylated substrates. HA mRNA was translated in the presence of wild-type (WT) (lanes 1, 3, 5, 7, and 8) or ERp57-/- knockout (KO) (lanes 2, 4, and 6) SP cells. ATCA was added after 5 min, and free thiols were alkylated with NEM after 30 min. Cells were harvested, and translated products were analyzed under non-reducing (NR) (lanes 1 and 2) and reducing conditions (R) (lanes 3-8). In addition, samples of each were treated with Tris[2-carboxyethyl]phosphine and AMS to modify disulfide linked thiols (lanes 5 and 6). As controls for AMS modification, the process was repeated with each protein translated with wild-type SP cells and cysteine residues fully reduced (dithiothreitol (DTT)) (lane 7) or fully oxidized (dipyridyl disulfide (DPS)) (lane 8) prior to NEM addition.
###end p 25
###begin p 26
###xml 164 167 164 167 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 273 274 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 279 280 279 280 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 265 280 265 280 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, <italic>A</italic> and <italic>B</italic></xref>
###xml 282 289 282 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 294 295 294 295 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 360 363 360 363 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 569 573 569 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A, B</italic>
###xml 579 580 579 580 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 561 580 561 580 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, <italic>A, B</italic>, and <italic>F</italic></xref>
###xml 682 685 682 685 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 699 700 699 700 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 693 700 693 700 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>B</italic></xref>
###xml 702 711 702 711 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1&#8211;5</italic>
###xml 764 766 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref16">16</xref>
To determine the consequence of an absence of ERp57 on disulfide bond formation within HA, we carried out a time course in the presence of either wild-type or ERp57-/- cells. At early time points, disulfide-bonded intermediates in the folding pathway were evident (Fig. 1, A and B, lanes 1 and 2). When the time courses are compared between wild-type and ERp57-/- cells, it was clear that the absence of ERp57 slowed down the formation of the fully oxidized faster migrating product, indicating that the native long range disulfides had not formed efficiently (Fig. 1, A, B, and F). Also, there was an accumulation of disulfide-bonded intermediates at early time points in the ERp57-/- cells (Fig. 1B, lanes 1-5). These results confirm those published previously (16) and demonstrate that our SP cell system can reproduce the folding defect caused by a lack of ERp57.
###end p 26
###begin p 27
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 3.</label>
###xml 9 94 9 94 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The R282A mutation in ERp57 abolishes its interaction with calnexin and calreticulin.</bold>
###xml 155 164 155 164 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2&#8211;5</italic>
###xml 184 186 184 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UT</italic>
###xml 195 201 195 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 1</italic>
###xml 433 436 433 436 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crt</italic>
###xml 439 440 439 440 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 455 458 455 458 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cnx</italic>
###xml 461 462 461 462 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 507 509 507 509 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WB</italic>
###xml 512 514 512 514 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 527 529 527 529 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IP</italic>
###xml 9 551 9 551 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="28"><bold>The R282A mutation in ERp57 abolishes its interaction with calnexin and calreticulin.</bold> HT1080 cells expressing various V5-tagged ERp57 constructs (<italic>lanes 2&#8211;5</italic>) or untransfected (<italic>UT</italic>) cells (<italic>lane 1</italic>) were cross-linked with BMH and lysed, and the ectopically expressed V5-tagged ERp57 was immunoisolated with a V5-specific antibody. The resulting immunoisolated material was separated on a reducing SDS-PAGE gel, and calreticulin (<italic>Crt</italic>) (<italic>A</italic>) or calnexin (<italic>Cnx</italic>) (<italic>B</italic>) was identified following Western blotting (<italic>WB</italic>). <italic>WT</italic>, wild type; <italic>IP</italic>, immunoprecipitation.</p>
###xml 9 551 9 551 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="28"><bold>The R282A mutation in ERp57 abolishes its interaction with calnexin and calreticulin.</bold> HT1080 cells expressing various V5-tagged ERp57 constructs (<italic>lanes 2&#8211;5</italic>) or untransfected (<italic>UT</italic>) cells (<italic>lane 1</italic>) were cross-linked with BMH and lysed, and the ectopically expressed V5-tagged ERp57 was immunoisolated with a V5-specific antibody. The resulting immunoisolated material was separated on a reducing SDS-PAGE gel, and calreticulin (<italic>Crt</italic>) (<italic>A</italic>) or calnexin (<italic>Cnx</italic>) (<italic>B</italic>) was identified following Western blotting (<italic>WB</italic>). <italic>WT</italic>, wild type; <italic>IP</italic>, immunoprecipitation.</p></caption>
###xml 551 551 551 551 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0090965720003"/>
###xml 0 551 0 551 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig3"><label>FIGURE 3.</label><caption><p textid="28"><bold>The R282A mutation in ERp57 abolishes its interaction with calnexin and calreticulin.</bold> HT1080 cells expressing various V5-tagged ERp57 constructs (<italic>lanes 2&#8211;5</italic>) or untransfected (<italic>UT</italic>) cells (<italic>lane 1</italic>) were cross-linked with BMH and lysed, and the ectopically expressed V5-tagged ERp57 was immunoisolated with a V5-specific antibody. The resulting immunoisolated material was separated on a reducing SDS-PAGE gel, and calreticulin (<italic>Crt</italic>) (<italic>A</italic>) or calnexin (<italic>Cnx</italic>) (<italic>B</italic>) was identified following Western blotting (<italic>WB</italic>). <italic>WT</italic>, wild type; <italic>IP</italic>, immunoprecipitation.</p></caption><graphic xlink:href="zbc0090965720003"/></fig>
FIGURE 3.The R282A mutation in ERp57 abolishes its interaction with calnexin and calreticulin. HT1080 cells expressing various V5-tagged ERp57 constructs (lanes 2-5) or untransfected (UT) cells (lane 1) were cross-linked with BMH and lysed, and the ectopically expressed V5-tagged ERp57 was immunoisolated with a V5-specific antibody. The resulting immunoisolated material was separated on a reducing SDS-PAGE gel, and calreticulin (Crt) (A) or calnexin (Cnx) (B) was identified following Western blotting (WB). WT, wild type; IP, immunoprecipitation.
###end p 27
###begin p 28
###xml 0 85 0 85 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The R282A mutation in ERp57 abolishes its interaction with calnexin and calreticulin.</bold>
###xml 146 155 146 155 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2&#8211;5</italic>
###xml 175 177 175 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">UT</italic>
###xml 186 192 186 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 1</italic>
###xml 424 427 424 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Crt</italic>
###xml 430 431 430 431 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 446 449 446 449 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Cnx</italic>
###xml 452 453 452 453 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 498 500 498 500 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WB</italic>
###xml 503 505 503 505 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 518 520 518 520 <italic xmlns:xlink="http://www.w3.org/1999/xlink">IP</italic>
The R282A mutation in ERp57 abolishes its interaction with calnexin and calreticulin. HT1080 cells expressing various V5-tagged ERp57 constructs (lanes 2-5) or untransfected (UT) cells (lane 1) were cross-linked with BMH and lysed, and the ectopically expressed V5-tagged ERp57 was immunoisolated with a V5-specific antibody. The resulting immunoisolated material was separated on a reducing SDS-PAGE gel, and calreticulin (Crt) (A) or calnexin (Cnx) (B) was identified following Western blotting (WB). WT, wild type; IP, immunoprecipitation.
###end p 28
###begin p 29
###xml 628 631 628 631 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 841 842 841 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 835 842 835 842 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1<italic>C</italic></xref>
###xml 976 979 976 979 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 995 996 995 996 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 1001 1002 1001 1002 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 987 1002 987 1002 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig1" ref-type="fig">Fig. 1, <italic>D</italic> and <italic>E</italic></xref>
###xml 1004 1013 1004 1013 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1&#8211;5</italic>
###xml 1019 1020 1019 1020 <italic xmlns:xlink="http://www.w3.org/1999/xlink">F</italic>
###xml 1173 1175 1173 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 1237 1240 1237 1240 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
In the absence of ERp57, HA would still interact with the calnexin cycle, but the absence of the oxidoreductase could have led to the slowdown in correct disulfide formation. To investigate this possibility, we carried out a time course in the presence of the glucosidase inhibitor castanospermine. Glycoproteins can be prevented from entering the calnexin cycle by inhibiting glucose trimming of the oligosaccharide side chain. To demonstrate the effectiveness of this treatment, we showed that HA was co-immunoprecipitated with antibodies to calnexin or calreticulin following translation in the presence of wild-type or ERp57-/- cells. However, when castanospermine was included in the translation, no HA was co-immunoprecipitated, demonstrating that castanospermine blocked the interaction between HA and calnexin or calreticulin (Fig. 1C). In addition, in the presence of castanospermine, HA formed native disulfide bonds with similar kinetics in both wild-type and ERp57-/- cells (Fig. 1, D and E, lanes 1-5, and F). Similar results were obtained previously when HA was folded post-translationally in isolated microsomal membranes in the presence of castanospermine (20). Hence, the lack of correct disulfide formation in the ERp57-/- cells was due to the targeting of the protein to the calnexin cycle where the protein becomes sequestered away from other oxidoreductases.
###end p 29
###begin p 30
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 4.</label>
###xml 9 84 9 84 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The R282A mutation in ERp57 dramatically reduces mixed disulfide formation.</bold>
###xml 178 179 178 179 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 185 186 185 186 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 191 192 191 192 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 248 251 248 251 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CST</italic>
###xml 263 264 263 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 316 318 316 318 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WB</italic>
###xml 390 397 390 397 <italic xmlns:xlink="http://www.w3.org/1999/xlink">non-red</italic>
###xml 400 401 400 401 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 406 407 406 407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 433 434 433 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 437 439 437 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 543 544 543 544 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 577 578 577 578 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 9 907 9 903 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="31"><bold>The R282A mutation in ERp57 dramatically reduces mixed disulfide formation.</bold> Stable HT1080 cell lines expressing various V5-tagged ERp57 constructs were treated with 25 m<sc>m</sc> NEM (<italic>A</italic> and <italic>B</italic>) or with NEM following treatment with castanospermine (<italic>CST</italic>) for 16 h (<italic>C</italic>) and lysed prior to SDS-PAGE and Western blotting (<italic>WB</italic>) with V5-specific antibody. Lysates were separated under non-reducing (<italic>non-red</italic>) (<italic>A</italic> and <italic>C</italic>) or reducing conditions (<italic>B</italic>). <italic>WT</italic>, wild type. V5-tagged ERp57 and mixed disulfides were immunoisolated from either the cys2,7 cell line (<italic>D</italic>) or the cys2,7 R282A cell line (<italic>E</italic>) with V5-specific antibody immobilized on agarose beads. Immunoisolated protein was eluted with SDS-PAGE buffer and separated by two-dimensional gel electrophoresis, first dimension non-reducing, second dimension reducing before silver staining. Spots corresponding to Ero1&#945; and tapasin were identified by mass spectrometry.</p>
###xml 9 907 9 903 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="31"><bold>The R282A mutation in ERp57 dramatically reduces mixed disulfide formation.</bold> Stable HT1080 cell lines expressing various V5-tagged ERp57 constructs were treated with 25 m<sc>m</sc> NEM (<italic>A</italic> and <italic>B</italic>) or with NEM following treatment with castanospermine (<italic>CST</italic>) for 16 h (<italic>C</italic>) and lysed prior to SDS-PAGE and Western blotting (<italic>WB</italic>) with V5-specific antibody. Lysates were separated under non-reducing (<italic>non-red</italic>) (<italic>A</italic> and <italic>C</italic>) or reducing conditions (<italic>B</italic>). <italic>WT</italic>, wild type. V5-tagged ERp57 and mixed disulfides were immunoisolated from either the cys2,7 cell line (<italic>D</italic>) or the cys2,7 R282A cell line (<italic>E</italic>) with V5-specific antibody immobilized on agarose beads. Immunoisolated protein was eluted with SDS-PAGE buffer and separated by two-dimensional gel electrophoresis, first dimension non-reducing, second dimension reducing before silver staining. Spots corresponding to Ero1&#945; and tapasin were identified by mass spectrometry.</p></caption>
###xml 907 907 903 903 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0090965720004"/>
###xml 0 907 0 903 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig4"><label>FIGURE 4.</label><caption><p textid="31"><bold>The R282A mutation in ERp57 dramatically reduces mixed disulfide formation.</bold> Stable HT1080 cell lines expressing various V5-tagged ERp57 constructs were treated with 25 m<sc>m</sc> NEM (<italic>A</italic> and <italic>B</italic>) or with NEM following treatment with castanospermine (<italic>CST</italic>) for 16 h (<italic>C</italic>) and lysed prior to SDS-PAGE and Western blotting (<italic>WB</italic>) with V5-specific antibody. Lysates were separated under non-reducing (<italic>non-red</italic>) (<italic>A</italic> and <italic>C</italic>) or reducing conditions (<italic>B</italic>). <italic>WT</italic>, wild type. V5-tagged ERp57 and mixed disulfides were immunoisolated from either the cys2,7 cell line (<italic>D</italic>) or the cys2,7 R282A cell line (<italic>E</italic>) with V5-specific antibody immobilized on agarose beads. Immunoisolated protein was eluted with SDS-PAGE buffer and separated by two-dimensional gel electrophoresis, first dimension non-reducing, second dimension reducing before silver staining. Spots corresponding to Ero1&#945; and tapasin were identified by mass spectrometry.</p></caption><graphic xlink:href="zbc0090965720004"/></fig>
FIGURE 4.The R282A mutation in ERp57 dramatically reduces mixed disulfide formation. Stable HT1080 cell lines expressing various V5-tagged ERp57 constructs were treated with 25 mm NEM (A and B) or with NEM following treatment with castanospermine (CST) for 16 h (C) and lysed prior to SDS-PAGE and Western blotting (WB) with V5-specific antibody. Lysates were separated under non-reducing (non-red) (A and C) or reducing conditions (B). WT, wild type. V5-tagged ERp57 and mixed disulfides were immunoisolated from either the cys2,7 cell line (D) or the cys2,7 R282A cell line (E) with V5-specific antibody immobilized on agarose beads. Immunoisolated protein was eluted with SDS-PAGE buffer and separated by two-dimensional gel electrophoresis, first dimension non-reducing, second dimension reducing before silver staining. Spots corresponding to Ero1alpha and tapasin were identified by mass spectrometry.
###end p 30
###begin p 31
###xml 0 75 0 75 <bold xmlns:xlink="http://www.w3.org/1999/xlink">The R282A mutation in ERp57 dramatically reduces mixed disulfide formation.</bold>
###xml 169 170 169 170 <sc xmlns:xlink="http://www.w3.org/1999/xlink">m</sc>
###xml 176 177 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 182 183 182 183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 239 242 239 242 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CST</italic>
###xml 254 255 254 255 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 307 309 307 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WB</italic>
###xml 381 388 381 388 <italic xmlns:xlink="http://www.w3.org/1999/xlink">non-red</italic>
###xml 391 392 391 392 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 397 398 397 398 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 424 425 424 425 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 428 430 428 430 <italic xmlns:xlink="http://www.w3.org/1999/xlink">WT</italic>
###xml 534 535 534 535 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 568 569 568 569 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
The R282A mutation in ERp57 dramatically reduces mixed disulfide formation. Stable HT1080 cell lines expressing various V5-tagged ERp57 constructs were treated with 25 mm NEM (A and B) or with NEM following treatment with castanospermine (CST) for 16 h (C) and lysed prior to SDS-PAGE and Western blotting (WB) with V5-specific antibody. Lysates were separated under non-reducing (non-red) (A and C) or reducing conditions (B). WT, wild type. V5-tagged ERp57 and mixed disulfides were immunoisolated from either the cys2,7 cell line (D) or the cys2,7 R282A cell line (E) with V5-specific antibody immobilized on agarose beads. Immunoisolated protein was eluted with SDS-PAGE buffer and separated by two-dimensional gel electrophoresis, first dimension non-reducing, second dimension reducing before silver staining. Spots corresponding to Ero1alpha and tapasin were identified by mass spectrometry.
###end p 31
###begin p 32
###xml 366 368 366 368 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref20">20</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref21">21</xref>
Under normal physiological conditions, HA would enter the calnexin cycle where it requires ERp57 for efficient folding. It has been previously suggested that the main advantage for HA to engage with the calnexin cycle is to slow down folding, thereby ensuring high yield of correctly folded protein and to prevent premature targeting of the protein for degradation (20, 21). Our results strongly suggest that HA can fold efficiently even in the absence of ERp57 if it is prevented from engaging with the calnexin cycle, suggesting that once HA has been dissociated from calnexin, other oxidoreductases can catalyze correct disulfide formation.
###end p 32
###begin p 33
###xml 0 64 0 64 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Is the Defect in Disulfide Formation Due to a Lack of Oxidation?</italic>
###xml 120 123 120 123 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 846 849 846 849 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
###xml 973 979 973 979 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig2" ref-type="fig">Fig. 2</xref>
###xml 981 991 981 991 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 5, 6</italic>
###xml 997 998 997 998 <italic xmlns:xlink="http://www.w3.org/1999/xlink">8</italic>
###xml 1071 1074 1071 1074 <sup xmlns:xlink="http://www.w3.org/1999/xlink">-/-</sup>
Is the Defect in Disulfide Formation Due to a Lack of Oxidation?-The defect in disulfide formation seen with HA in ERp57-/- cells could be a result of a lack of oxidation or isomerization of non-native disulfides. To determine whether there is a defect in oxidation, we measured the extent of disulfide oxidation by carrying out modification with the alkylating agent AMS. In this experiment, SP cells were treated with NEM to block free thiols and then washed to remove NEM, reduced, and treated with AMS. AMS reacts with free cysteine residues formed, and in doing so, increases the molecular mass by 0.5 kDa per cysteine modified. Hence, if disulfides had formed during translation, the cysteine residues involved would be modified with AMS, resulting in a slower migrating product. When HA was translated in the presence of wild-type or ERp57-/- cells and the translation products were modified with AMS, the resulting product migrated with the fully oxidized protein (Fig. 2, lanes 5, 6, and 8). These results clearly indicate that the defect observed with the ERp57-/- cells is not due to diminished oxidation and is most likely to be due to a lack of isomerization of disulfides. The implication is that an alternate oxidoreductase, possibly PDI, catalyzes the formation of both native and non-native disulfides and that ERp57 then reshuffles the non-native disulfides. The formation of non-native disulfides is likely to be more prevalent in substrates with complicated patterns of disulfides. These results provide further evidence that the essential function of ERp57 is as an isomerase rather than oxidase. Such a clear demarcation of roles for ERp57 and other oxidoreductases suggests that they are able to catalyze distinct reactions within the ER.
###end p 33
###begin p 34
###xml 0 86 0 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Can ERp57 Form Mixed Disulfides with Substrates When Not in Association with Calnexin?</italic>
###xml 162 164 162 164 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref10">10</xref>
###xml 238 240 238 240 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref11">11</xref>
###xml 242 244 242 244 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 517 525 517 525 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vitro</italic>
###xml 527 529 527 529 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref22">22</xref>
###xml 938 940 938 940 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XX</italic>
###xml 977 979 977 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">XX</italic>
Can ERp57 Form Mixed Disulfides with Substrates When Not in Association with Calnexin?-It is known that the b' domain of PDI contains a polypeptide binding site (10) and that the binding of ERp57 to calnexin is mediated by its b' domain (11, 22). To prevent ERp57 associating with calnexin or calreticulin, we aimed to abolish the interaction between these proteins by introducing a single point mutation (R282A) into the b' domain of ERp57, which has previously been shown to completely abrogate binding to calnexin in vitro (22). To assay for ERp57 substrate interactions, we took advantage of the fact that during the initial reduction of a non-native disulfide, a mixed disulfide between the enzyme and substrate can be trapped if the second cysteine in the oxidoreductase active site is mutated to alanine. We generated stable cell lines that were expressing V5-tagged versions of ERp57, namely wild-type, R282A, cys2,7 (where both CXXC active sites have been mutated to CXXA), and cys2,7 R282A. Using such an approach, we were able to determine whether preventing an association of ERp57 with calnexin and calreticulin prevented the trapping of mixed disulfides between enzyme and glycoprotein substrate.
###end p 34
###begin p 35
###xml 105 112 105 112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
###xml 264 265 264 265 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 258 265 258 265 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 286 287 286 287 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 280 287 280 287 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 433 434 433 434 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref4">4</xref>
###xml 485 486 485 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 479 486 479 486 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>A</italic></xref>
###xml 507 508 507 508 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 501 508 501 508 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3<italic>B</italic></xref>
###xml 604 605 604 605 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 610 611 610 611 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 596 611 596 611 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, <italic>A</italic> and <italic>B</italic></xref>
###xml 613 620 613 620 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 625 626 625 626 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 961 962 961 962 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 967 968 967 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 953 968 953 968 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3, <italic>A</italic> and <italic>B</italic></xref>
###xml 970 980 970 980 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1, 2</italic>
###xml 986 987 986 987 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 1076 1082 1076 1082 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig3" ref-type="fig">Fig. 3</xref>
###xml 1084 1091 1084 1091 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3</italic>
###xml 1096 1097 1096 1097 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
To verify that the R282A mutation prevented complex formation between ERp57 and calnexin or calreticulin in vivo, we added a cross-linking agent to intact cells, lysed the cells, and then analyzed V5-immunoisolated material for the presence of calreticulin (Fig. 3A) or calnexin (Fig. 3B). It has been demonstrated previously that calnexin and calreticulin form complexes with ERp57 that can be stabilized by cross-linking with BMH (4). Complexes between ERp57 and calreticulin (Fig. 3A) or calnexin (Fig. 3B) were isolated from stable cell lines expressing V5-tagged wild-type and cys2,7 ERp57 (Fig. 3, A and B, lanes 2 and 4). Some non-cross-linked calreticulin, and to a lesser extent, calnexin was co-immunoprecipitated with the V5 antibody from the wild-type and cys2,7 ERp57 cell line. Calnexin and calreticulin were absent from control immunoisolated material from untransfected cells demonstrating the specificity of the interaction with ERp57 (Fig. 3, A and B, lanes 1, 2, and 4). The R282A and the cys2,7 R282A ERp57 did not associate with calreticulin or calnexin (Fig. 3, lanes 3 and 5). Hence, we were able to create stable cell lines expressing versions of ERp57 that are not associated with calreticulin or calnexin and have the potential to form mixed disulfides with substrates proteins.
###end p 35
###begin p 36
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 199 206 199 206 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 208 214 208 214 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 376 377 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 370 377 370 377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>A</italic></xref>
###xml 379 385 379 385 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 647 648 647 648 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C</italic>
###xml 641 648 641 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>C</italic></xref>
###xml 1098 1099 1098 1099 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1092 1099 1092 1099 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>B</italic></xref>
When cell lysates from the cys2,7 cell line were separated under non-reducing conditions and probed with the V5 antibody, several mixed disulfides between ERp57 and substrate proteins were observed (Fig. 4A, lane 3). When the cys2,7 R282A cell line was analyzed under identical conditions, a dramatic reduction in the number and amount of mixed disulfides was observed (Fig. 4A, lane 4). The addition of castanospermine to the cys2,7 R282A cell line prior to cell lysis did not alter these residual mixed disulfides between ERp57 and substrate proteins, confirming that these interactions did not require association of ERp57 with calnexin (Fig. 4C). The fact that the population of mixed disulfides did not increase upon castanospermine treatment also indicates that the decrease in mixed disulfide formation is not due to the substrates being unable to interact with cys2,7 R282A ERp57 due to their sequestration in the calnexin cycle. The identity of the V5-reactive slower migrating bands as mixed disulfides was confirmed by their disappearance when separated under reducing conditions (Fig. 4B).
###end p 36
###begin p 37
###xml 186 187 186 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 298 299 298 299 <italic xmlns:xlink="http://www.w3.org/1999/xlink">E</italic>
###xml 292 299 292 299 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>E</italic></xref>
###xml 426 427 426 427 <italic xmlns:xlink="http://www.w3.org/1999/xlink">D</italic>
###xml 420 427 420 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig4" ref-type="fig">Fig. 4<italic>D</italic></xref>
###xml 953 954 949 950 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref8">8</xref>
We have previously been able to identify substrates of ERp57 by immunoisolation of the mixed disulfides followed by two-dimensional gel analysis, silver staining, and mass spectrometry (6). We carried out a similar analysis with the mixed disulfides isolated from the cys2,7 R282A cell line (Fig. 4E). A two-dimensional non-reducing/reducing gel of mixed disulfides from the cys2,7 cell line is included for comparison (Fig. 4D). Only a few spots were visible following silver staining from the cys2,7 R282A cell line, and unfortunately, the amount of product isolated was insufficient for mass spectrometry analysis for most of the substrates; however, two proteins, Ero1alpha and tapasin, were identified. It would appear that the ability of ERp57 to form mixed disulfides with these proteins is independent of its association with calnexin, a conclusion that is consistent with what is already known concerning the interaction of ERp57 with tapasin (8).
###end p 37
###begin p 38
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 5.</label>
###xml 9 112 9 108 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ERp57 forms mixed disulfides with tapasin and Ero1&#945; in the absence of an interaction with calnexin.</bold>
###xml 112 113 108 109 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 232 236 224 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trns</italic>
###xml 302 305 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CST</italic>
###xml 400 407 392 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 409 410 401 402 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 412 413 404 405 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 419 420 411 412 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 473 480 465 472 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3</italic>
###xml 482 483 474 475 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 485 486 477 478 <italic xmlns:xlink="http://www.w3.org/1999/xlink">7</italic>
###xml 492 493 484 485 <italic xmlns:xlink="http://www.w3.org/1999/xlink">8</italic>
###xml 587 589 575 577 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ip</italic>
###xml 612 613 600 601 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 818 824 806 812 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 1</italic>
###xml 829 830 817 818 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 852 859 840 847 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 4</italic>
###xml 864 865 852 853 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 973 980 961 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 5</italic>
###xml 985 986 973 974 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 989 991 977 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HC</italic>
###xml 9 1005 9 993 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="39"><bold>ERp57 forms mixed disulfides with tapasin and Ero1&#945; in the absence of an interaction with calnexin.</bold><italic>A</italic>, Ero1&#945; or tapasin mRNA was translated in the presence of SP cells from the ERp57 cys 2,7 cell line. Translations (<italic>trns</italic>) were carried out in the presence or absence of castanospermine (<italic>CST</italic>) as indicated. Products of translation were separated directly under non-reducing conditions (<italic>lanes 1</italic>, <italic>2</italic>, <italic>5</italic>, and <italic>6</italic>) or were first immunoisolated with the V5 antibody (<italic>lanes 3</italic>, <italic>4</italic>, <italic>7</italic>, and <italic>8</italic>). The mobilities of tapasin, Ero1&#945;, and their mixed disulfides with ERp57 are indicated. <italic>ip</italic>, immunoprecipitation. <italic>B</italic>, MHC class I heavy chain mRNA was translated in the presence of SP cells from either the cys 2,7 or the cys 2,7 R282A cell line as indicated. Translation products were immunoisolated with either tapasin (<italic>lane 1</italic> and <italic>2</italic>) or the V5 antibody (<italic>lanes 4</italic> and <italic>5</italic>). A translation was also carried out in the absence of added mRNA and immunoisolated with the V5 antibody (<italic>lanes 5</italic> and <italic>6</italic>). <italic>HC</italic>, heavy chain.</p>
###xml 9 1005 9 993 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="39"><bold>ERp57 forms mixed disulfides with tapasin and Ero1&#945; in the absence of an interaction with calnexin.</bold><italic>A</italic>, Ero1&#945; or tapasin mRNA was translated in the presence of SP cells from the ERp57 cys 2,7 cell line. Translations (<italic>trns</italic>) were carried out in the presence or absence of castanospermine (<italic>CST</italic>) as indicated. Products of translation were separated directly under non-reducing conditions (<italic>lanes 1</italic>, <italic>2</italic>, <italic>5</italic>, and <italic>6</italic>) or were first immunoisolated with the V5 antibody (<italic>lanes 3</italic>, <italic>4</italic>, <italic>7</italic>, and <italic>8</italic>). The mobilities of tapasin, Ero1&#945;, and their mixed disulfides with ERp57 are indicated. <italic>ip</italic>, immunoprecipitation. <italic>B</italic>, MHC class I heavy chain mRNA was translated in the presence of SP cells from either the cys 2,7 or the cys 2,7 R282A cell line as indicated. Translation products were immunoisolated with either tapasin (<italic>lane 1</italic> and <italic>2</italic>) or the V5 antibody (<italic>lanes 4</italic> and <italic>5</italic>). A translation was also carried out in the absence of added mRNA and immunoisolated with the V5 antibody (<italic>lanes 5</italic> and <italic>6</italic>). <italic>HC</italic>, heavy chain.</p></caption>
###xml 1005 1005 993 993 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0090965720005"/>
###xml 0 1005 0 993 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig5"><label>FIGURE 5.</label><caption><p textid="39"><bold>ERp57 forms mixed disulfides with tapasin and Ero1&#945; in the absence of an interaction with calnexin.</bold><italic>A</italic>, Ero1&#945; or tapasin mRNA was translated in the presence of SP cells from the ERp57 cys 2,7 cell line. Translations (<italic>trns</italic>) were carried out in the presence or absence of castanospermine (<italic>CST</italic>) as indicated. Products of translation were separated directly under non-reducing conditions (<italic>lanes 1</italic>, <italic>2</italic>, <italic>5</italic>, and <italic>6</italic>) or were first immunoisolated with the V5 antibody (<italic>lanes 3</italic>, <italic>4</italic>, <italic>7</italic>, and <italic>8</italic>). The mobilities of tapasin, Ero1&#945;, and their mixed disulfides with ERp57 are indicated. <italic>ip</italic>, immunoprecipitation. <italic>B</italic>, MHC class I heavy chain mRNA was translated in the presence of SP cells from either the cys 2,7 or the cys 2,7 R282A cell line as indicated. Translation products were immunoisolated with either tapasin (<italic>lane 1</italic> and <italic>2</italic>) or the V5 antibody (<italic>lanes 4</italic> and <italic>5</italic>). A translation was also carried out in the absence of added mRNA and immunoisolated with the V5 antibody (<italic>lanes 5</italic> and <italic>6</italic>). <italic>HC</italic>, heavy chain.</p></caption><graphic xlink:href="zbc0090965720005"/></fig>
FIGURE 5.ERp57 forms mixed disulfides with tapasin and Ero1alpha in the absence of an interaction with calnexin.A, Ero1alpha or tapasin mRNA was translated in the presence of SP cells from the ERp57 cys 2,7 cell line. Translations (trns) were carried out in the presence or absence of castanospermine (CST) as indicated. Products of translation were separated directly under non-reducing conditions (lanes 1, 2, 5, and 6) or were first immunoisolated with the V5 antibody (lanes 3, 4, 7, and 8). The mobilities of tapasin, Ero1alpha, and their mixed disulfides with ERp57 are indicated. ip, immunoprecipitation. B, MHC class I heavy chain mRNA was translated in the presence of SP cells from either the cys 2,7 or the cys 2,7 R282A cell line as indicated. Translation products were immunoisolated with either tapasin (lane 1 and 2) or the V5 antibody (lanes 4 and 5). A translation was also carried out in the absence of added mRNA and immunoisolated with the V5 antibody (lanes 5 and 6). HC, heavy chain.
###end p 38
###begin p 39
###xml 0 103 0 99 <bold xmlns:xlink="http://www.w3.org/1999/xlink">ERp57 forms mixed disulfides with tapasin and Ero1&#945; in the absence of an interaction with calnexin.</bold>
###xml 103 104 99 100 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 223 227 215 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">trns</italic>
###xml 293 296 285 288 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CST</italic>
###xml 391 398 383 390 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 400 401 392 393 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 403 404 395 396 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 410 411 402 403 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 464 471 456 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3</italic>
###xml 473 474 465 466 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 476 477 468 469 <italic xmlns:xlink="http://www.w3.org/1999/xlink">7</italic>
###xml 483 484 475 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">8</italic>
###xml 578 580 566 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">ip</italic>
###xml 603 604 591 592 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 809 815 797 803 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 1</italic>
###xml 820 821 808 809 <italic xmlns:xlink="http://www.w3.org/1999/xlink">2</italic>
###xml 843 850 831 838 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 4</italic>
###xml 855 856 843 844 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 964 971 952 959 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 5</italic>
###xml 976 977 964 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 980 982 968 970 <italic xmlns:xlink="http://www.w3.org/1999/xlink">HC</italic>
ERp57 forms mixed disulfides with tapasin and Ero1alpha in the absence of an interaction with calnexin.A, Ero1alpha or tapasin mRNA was translated in the presence of SP cells from the ERp57 cys 2,7 cell line. Translations (trns) were carried out in the presence or absence of castanospermine (CST) as indicated. Products of translation were separated directly under non-reducing conditions (lanes 1, 2, 5, and 6) or were first immunoisolated with the V5 antibody (lanes 3, 4, 7, and 8). The mobilities of tapasin, Ero1alpha, and their mixed disulfides with ERp57 are indicated. ip, immunoprecipitation. B, MHC class I heavy chain mRNA was translated in the presence of SP cells from either the cys 2,7 or the cys 2,7 R282A cell line as indicated. Translation products were immunoisolated with either tapasin (lane 1 and 2) or the V5 antibody (lanes 4 and 5). A translation was also carried out in the absence of added mRNA and immunoisolated with the V5 antibody (lanes 5 and 6). HC, heavy chain.
###end p 39
###begin p 40
###xml 323 324 319 320 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 317 324 313 320 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 326 333 322 329 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 3</italic>
###xml 338 339 334 335 <italic xmlns:xlink="http://www.w3.org/1999/xlink">7</italic>
###xml 453 454 449 450 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 447 454 443 450 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 456 463 452 459 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 4</italic>
###xml 468 469 464 465 <italic xmlns:xlink="http://www.w3.org/1999/xlink">8</italic>
###xml 641 642 633 634 <italic xmlns:xlink="http://www.w3.org/1999/xlink">A</italic>
###xml 635 642 627 634 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>A</italic></xref>
###xml 644 651 636 643 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 656 657 648 649 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
As an alternative approach, we also translated either Ero1alpha or tapasin mRNA into SP cells isolated from the ERp57 cys 2,7 cell line. Both proteins were able to form mixed disulfides with ERp57, as judged by immunoisolation with the V5 antibody of complexes between the radiolabeled translation product and ERp57 (Fig. 5A, lanes 3 and 7). The complexes were still seen when the translations were carried out in the presence of castanospermine (Fig. 5A, lanes 4 and 8). The slight decrease in mobility of the ero1alpha and tapasin translation products indicates the inhibition of glucose trimming in the presence of castanospermine (Fig. 5A, lanes 2 and 6). These results clearly demonstrate that these particular client proteins do not need to enter the calnexin cycle to bind to ERp57.
###end p 40
###begin p 41
###xml 0 9 0 9 <label xmlns:xlink="http://www.w3.org/1999/xlink">FIGURE 6.</label>
###xml 9 75 9 72 <bold xmlns:xlink="http://www.w3.org/1999/xlink">&#946;1-integrin folding requires both ERp57 and the calnexin cycle.</bold>
###xml 215 222 209 216 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 224 225 218 219 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 231 232 225 226 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 246 253 240 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 255 256 249 250 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 262 263 256 257 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 285 288 279 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CST</italic>
###xml 309 312 303 306 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Con</italic>
###xml 408 417 399 408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lanes 1&#8211;6</italic>
###xml 489 495 480 486 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
###xml 9 533 9 524 <p xmlns:xlink="http://www.w3.org/1999/xlink" textid="42"><bold>&#946;1-integrin folding requires both ERp57 and the calnexin cycle.</bold> &#946;1-integrin was translated in the presence of HT1080 SP cells stably expressing V5-tagged ERp57 R282A and preincubated in the presence (<italic>lanes 2</italic>, <italic>4</italic>, and <italic>6</italic>) or absence (<italic>lanes 1</italic>, <italic>3</italic>, and <italic>5</italic>) of castanospermine (<italic>CST</italic>). The control lane (<italic>Con</italic>) shows &#946;1-integrin translated for 120 min in the presence of untransfected HT1080 SP cells. <italic>Lanes 1&#8211;6</italic> were also analyzed by densitometry, and the band intensity was plotted <italic>versus</italic> the gel position for each time point.</p>
###xml 9 533 9 524 <caption xmlns:xlink="http://www.w3.org/1999/xlink"><p textid="42"><bold>&#946;1-integrin folding requires both ERp57 and the calnexin cycle.</bold> &#946;1-integrin was translated in the presence of HT1080 SP cells stably expressing V5-tagged ERp57 R282A and preincubated in the presence (<italic>lanes 2</italic>, <italic>4</italic>, and <italic>6</italic>) or absence (<italic>lanes 1</italic>, <italic>3</italic>, and <italic>5</italic>) of castanospermine (<italic>CST</italic>). The control lane (<italic>Con</italic>) shows &#946;1-integrin translated for 120 min in the presence of untransfected HT1080 SP cells. <italic>Lanes 1&#8211;6</italic> were also analyzed by densitometry, and the band intensity was plotted <italic>versus</italic> the gel position for each time point.</p></caption>
###xml 533 533 524 524 <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="zbc0090965720006"/>
###xml 0 533 0 524 <fig xmlns:xlink="http://www.w3.org/1999/xlink" position="float" id="fig6"><label>FIGURE 6.</label><caption><p textid="42"><bold>&#946;1-integrin folding requires both ERp57 and the calnexin cycle.</bold> &#946;1-integrin was translated in the presence of HT1080 SP cells stably expressing V5-tagged ERp57 R282A and preincubated in the presence (<italic>lanes 2</italic>, <italic>4</italic>, and <italic>6</italic>) or absence (<italic>lanes 1</italic>, <italic>3</italic>, and <italic>5</italic>) of castanospermine (<italic>CST</italic>). The control lane (<italic>Con</italic>) shows &#946;1-integrin translated for 120 min in the presence of untransfected HT1080 SP cells. <italic>Lanes 1&#8211;6</italic> were also analyzed by densitometry, and the band intensity was plotted <italic>versus</italic> the gel position for each time point.</p></caption><graphic xlink:href="zbc0090965720006"/></fig>
FIGURE 6.beta1-integrin folding requires both ERp57 and the calnexin cycle. beta1-integrin was translated in the presence of HT1080 SP cells stably expressing V5-tagged ERp57 R282A and preincubated in the presence (lanes 2, 4, and 6) or absence (lanes 1, 3, and 5) of castanospermine (CST). The control lane (Con) shows beta1-integrin translated for 120 min in the presence of untransfected HT1080 SP cells. Lanes 1-6 were also analyzed by densitometry, and the band intensity was plotted versus the gel position for each time point.
###end p 41
###begin p 42
###xml 0 66 0 63 <bold xmlns:xlink="http://www.w3.org/1999/xlink">&#946;1-integrin folding requires both ERp57 and the calnexin cycle.</bold>
###xml 206 213 200 207 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2</italic>
###xml 215 216 209 210 <italic xmlns:xlink="http://www.w3.org/1999/xlink">4</italic>
###xml 222 223 216 217 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 237 244 231 238 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 1</italic>
###xml 246 247 240 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink">3</italic>
###xml 253 254 247 248 <italic xmlns:xlink="http://www.w3.org/1999/xlink">5</italic>
###xml 276 279 270 273 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CST</italic>
###xml 300 303 294 297 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Con</italic>
###xml 399 408 390 399 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Lanes 1&#8211;6</italic>
###xml 480 486 471 477 <italic xmlns:xlink="http://www.w3.org/1999/xlink">versus</italic>
beta1-integrin folding requires both ERp57 and the calnexin cycle. beta1-integrin was translated in the presence of HT1080 SP cells stably expressing V5-tagged ERp57 R282A and preincubated in the presence (lanes 2, 4, and 6) or absence (lanes 1, 3, and 5) of castanospermine (CST). The control lane (Con) shows beta1-integrin translated for 120 min in the presence of untransfected HT1080 SP cells. Lanes 1-6 were also analyzed by densitometry, and the band intensity was plotted versus the gel position for each time point.
###end p 42
###begin p 43
###xml 281 282 281 282 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 275 282 275 282 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 453 455 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 575 576 575 576 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 569 576 569 576 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 787 788 787 788 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 781 788 781 788 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 790 796 790 796 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 3</italic>
###xml 867 869 867 869 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref14">14</xref>
###xml 871 873 871 873 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref23">23</xref>
###xml 1052 1053 1052 1053 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1046 1053 1046 1053 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 1055 1061 1055 1061 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 2</italic>
###xml 1174 1175 1174 1175 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1168 1175 1168 1175 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 1177 1183 1177 1183 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 1229 1235 1229 1235 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 4</italic>
###xml 1375 1376 1375 1376 <italic xmlns:xlink="http://www.w3.org/1999/xlink">B</italic>
###xml 1369 1376 1369 1376 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig5" ref-type="fig">Fig. 5<italic>B</italic></xref>
###xml 1378 1384 1378 1384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 6</italic>
To investigate further the requirement for ERp57 to enter the calnexin cycle to recognize substrate proteins, we translated MHC class I heavy chain in the presence of cys 2,7 or cys 2,7 R282A SP cells and immunoisolated mixed disulfides with either tapasin or V5 antibodies (Fig. 5B). We have previously demonstrated that MHC class I heavy chain forms a number of complexes when translated in the presence of SP cells expressing V5-tagged ERp57 cys2,7 (14). These have been characterized and correspond to a heavy chain-tapasin and a heavy chain-tapasin-ERp57 complex (Fig. 5B) and are part of the peptide-loading complex. In addition, a number of mixed disulfides are formed between heavy chain and ERp57, which can be distinguished by their immunoisolation with the V5 antibody (Fig. 5B, lane 3) and by the fact that they occur outside the peptide-loading complex (14, 23). When heavy chain was translated in the presence of the ERp57 R282A cys2,7 cell line, the heavy chain-tapasin and the heavy chain-tapasin ERp57 complexes were still seen (Fig. 5B, lane 2). However, under identical conditions, the mixed disulfides between heavy chain and ERp57 were abolished (Fig. 5B, lane 4). The radiolabeled product seen at 57 kDa in lane 4 corresponds to endogenous ERp57 translated in this cell line as it is also present when no RNA is added to the translation reaction (Fig. 5B, lane 6). These results demonstrate that the tapasin-ERp57 interaction occurs irrespective of the ERp57 association with calnexin. In contrast, the interaction between ERp57 and calnexin is necessary for ERp57 to form mixed disulfides with heavy chain. These results further demonstrate that the ability of ERp57 to bind and act upon most substrates requires an initial interaction between the substrate glycoprotein and calnexin.
###end p 43
###begin p 44
###xml 757 759 757 759 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref24">24</xref>
The main consequence of introducing a point mutation in ERp57, which reduces its affinity for calnexin, is to practically eliminate the formation of mixed disulfides with substrates. This observation suggests that for ERp57 to function as an isomerase or reductase, it must be associated with the calnexin cycle. Conversely, the ability of ERp57 to interact with a small defined set of proteins does not seem to be abrogated by the R282A mutation or by blocking glucose trimming, suggesting that the interaction with these proteins is not mediated by the same site as that required for calnexin binding. This conclusion would explain how ERp57 can form a stable interaction with both calreticulin and tapasin within the MHC class I peptide-loading complex (24).
###end p 44
###begin p 45
###xml 0 85 0 85 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Can ERp57 Assist the Folding of Proteins When It Is Not in Association with Calnexin?</italic>
###xml 367 368 364 365 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 555 556 549 550 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 1392 1393 1371 1372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref6">6</xref>
###xml 1396 1402 1375 1381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 1404 1410 1383 1389 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lane 7</italic>
###xml 1574 1580 1550 1556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 1582 1592 1558 1568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">lanes 2, 4</italic>
###xml 1598 1599 1574 1575 <italic xmlns:xlink="http://www.w3.org/1999/xlink">6</italic>
###xml 1954 1960 1930 1936 <xref xmlns:xlink="http://www.w3.org/1999/xlink" rid="fig6" ref-type="fig">Fig. 6</xref>
###xml 2316 2317 2292 2293 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
Can ERp57 Assist the Folding of Proteins When It Is Not in Association with Calnexin?-The results obtained with HA would suggest that the function of ERp57 is redundant if proteins are prevented from entering the calnexin cycle. However, we have shown previously that when beta1-integrin is prevented from entering the calnexin cycle, it no longer folds efficiently (6). These experiments were carried out by including castanospermine in the translation reaction, which prevented beta1-integrin entering the calnexin cycle and caused a defect in folding (6). To determine whether this defect was due to ERp57 being sequestered into the calnexin cycle, we investigated whether beta1-integrin could fold correctly in the ERp57 R282A cell line. In this cell line, beta1-integrin would be expected to fold correctly as endogenous ERp57 is present and interacts with the calnexin cycle. However, when the translations are carried out in the presence of castanospermine, beta1-integrin does not interact with the calnexin cycle, so we can test whether any defect in folding can be reversed by the presence of the ERp57 R282A mutant that is not in association with calnexin. beta1-integrin is a complex glycoprotein with over 20 disulfides and 12 glycosylation sites. beta1-integrin migrates as a distinct band when the correctly disulfide-bonded protein is separated under non-reducing conditions (6) (Fig. 6, lane 7). When castanospermine was included during translation of beta1-integrin in the presence of ERp57 R282A cells, a clear defect in disulfide formation was observed (Fig. 6, lanes 2, 4, and 6). A diffuse pattern indicative of heterogeneous, non-native disulfides was seen throughout the time course in the presence of castanospermine, whereas the protein folded into a more compact structure in the absence of castanospermine. Densitometry scans of the each lane confirmed that a more compact band was observed in the absence of castanospermine (Fig. 6). Hence, for this substrate, there is a requirement to engage with the calnexin cycle to ensure correct disulfide formation; blocking such an interaction does not allow correct folding by providing access to other oxidoreductases including non-calnexin-associated ERp57. Presumably, the combination of unstructured cysteine-rich domains and the extensive N-linked glycosylation preclude correct folding in the absence of calnexin. The crucial role of ERp57 in the folding of beta1-integrin illustrates the requirement for an oxidoreductase to be associated with calnexin to facilitate disulfide isomerization within complex glycoproteins.
###end p 45
###begin p 46
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Summary</italic>
###xml 208 209 208 209 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref2">2</xref>
###xml 1257 1259 1257 1259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref25">25</xref>
###xml 1272 1274 1272 1274 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref26">26</xref>
###xml 1276 1278 1276 1278 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref27">27</xref>
Summary-The presence of multiple oxidoreductases in the ER lumen suggests that each enzyme has the ability to act on a specific subset of substrates or that each enzyme catalyzes a specific type of reaction (2). It is clear from our results with ERp57 that a combination of these two possibilities can occur. Substrate specificity is directly related to the sequestration of glycoproteins into the calnexin cycle, but this specificity is not a consequence of a direct interaction of ERp57 with substrates; rather, it is mediated by the presence of a monoglucosylated oligosaccharide side chain. In addition, the essential function of ERp57 is as an isomerase as oxidation of substrates can occur in the absence of the enzyme. Hence, one of the reasons for the proliferation of ER oxidoreductases is the fact that the substrates for disulfide formation can be sequestered into subcomplexes, which require both spatial and temporal coordination with oxidoreductases to catalyze oxidation, isomerization, or reduction. The calnexin cycle and ERp57 is one example of such a partitioning of substrates, but it may also be the case that substrates associating with BiP require specific oxidoreductases to associate and facilitate disulfide reactions. Indeed, P5 (25) and ERdj5 (26, 27) are known to associate with BiP and may well facilitate disulfide exchange reactions within such a complex.
###end p 46
###begin p 47
###xml 91 93 91 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref28">28</xref>
###xml 370 372 370 372 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="ref29">29</xref>
The absence of a specific oxidoreductase for glycoprotein folding within lower eukaryotes (28) suggests that substrates entering the calnexin cycle in these organisms already contain the correct disulfides. The calnexin cycle may have initially evolved to fulfil a function distinct from protein folding such as retention of unfolded or incompletely assembled proteins (29). An inevitable consequence of the sequestration of glycoproteins would appear to be a slowing of the rate of folding, particularly if the glycoprotein has a complex set of disulfides. Hence, an evolutionary advantage would be afforded to the association of an oxidoreductase with the calnexin cycle to allow the isomerization of non-native disulfides, thereby accelerating folding. Unlike an oxidoreductase that is not associated with the calnexin cycle, ERp57 does not need to bind directly to the glycoprotein as it would be brought into close proximity to its substrate by its binding to calnexin. Hence, the substrate-binding function of PDI, which is mediated via the b' domain, is lost in ERp57 so that when the binding to calnexin is abrogated, it can no longer facilitate disulfide isomerization even with its authentic substrates. Thus, the specificity of ER oxidoreductases may in part be explained by their interaction with other proteins rather than a direct interaction between enzyme and substrate out with the active site.
###end p 47
###begin p 48
We acknowledge Natalio Garbi, Gunter Hammerling, Martin Humphries, Peter Cresswell, and Mary Jane Gething for reagents used during this work. We also thank David Knight and Emma Keevil for the mass spectrometry.
###end p 48
###begin p 49
###xml 246 247 246 247 <italic xmlns:xlink="http://www.w3.org/1999/xlink">N</italic>
The abbreviations used are: ER, endoplasmic reticulum; PDI, protein disulfide isomerase; ATCA, aurin tricarboxylic acid; AMS, 4-acetamido-4'maleimidylstilbene-2,2'-disufhonic acid; BMH, bismaleimidohexane; HA, influenza virus hemagglutinin; NEM, N-ethylmaleimide; SP cells, semipermeabilized cells; MHC, major histocompatibility complex.
###end p 49

